Cite
QOLP-23. PHASE II RANDOMISED PLACEBO-CONTROLLED DOUBLE-BLIND STUDY OF ACETAZOLAMIDE VERSUS PLACEBO FOR CEREBRAL OEDEMA IN RECURRENT AND/OR PROGRESSIVE HIGH-GRADE GLIOMA REQUIRING TREATMENT WITH DEXAMETHASONE
MLA
Agar, M., et al. Qolp-23. Phase Ii Randomised Placebo-Controlled Double-Blind Study of Acetazolamide Versus Placebo for Cerebral Oedema in Recurrent And/Or Progressive High-Grade Glioma Requiring Treatment with Dexamethasone. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1257438007&authtype=sso&custid=ns315887.
APA
Agar, M., Nowak, A., Hovey, E., Barnes, E., Simes, J., Vardy, J., Wheeler, H., Leonard, R., Hall, M., Tim, E., Spyridopoulos, D., Sim, H.-W., Lwin, Z., Dowling, A., Harrup, R., Jennens, R., Kichenadasse, G., Dunlop, T., Gzell, C., & Koh, E.-S. (2020). Qolp-23. Phase Ii Randomised Placebo-Controlled Double-Blind Study of Acetazolamide Versus Placebo for Cerebral Oedema in Recurrent And/Or Progressive High-Grade Glioma Requiring Treatment with Dexamethasone.
Chicago
Agar, M, A Nowak, E Hovey, E Barnes, J Simes, J Vardy, H Wheeler, et al. 2020. “Qolp-23. Phase Ii Randomised Placebo-Controlled Double-Blind Study of Acetazolamide Versus Placebo for Cerebral Oedema in Recurrent And/Or Progressive High-Grade Glioma Requiring Treatment with Dexamethasone.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1257438007&authtype=sso&custid=ns315887.